NCT00018850View on ClinicalTrials.gov

5HT3 Antagonism and Auditory Gating in Schizophrenia

NACompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1998

Study Completion Date

June 30, 2003

Conditions

Schizophrenia

Interventions

DRUG

ondansetron

BEHAVIORAL

neuropsychological testing

DRUG

nicotine

DRUG

haloperidol

Trial Locations (1)

80013

VAMC, Denver

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00018850 - 5HT3 Antagonism and Auditory Gating in Schizophrenia | Biotech Hunter | Biotech Hunter